⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44897 | 0.71 | — | — | |
| SCHEMBL3668087 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL4462514 | 0.67 | — | — | |
| SCHEMBL2204908 | 0.67 | — | — | |
| SCHEMBL5985549 | 0.64 | — | — | |
| Hydrochloric Acid SCHEMBL980613 | 0.64 | BLM (0.36) | — | |
| SCHEMBL5984536 | 0.64 | — | — | |
| SCHEMBL74382 | 0.61 | — | — | |
| SCHEMBL6279248 | 0.61 | — | — | |
| SCHEMBL24606238 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060257917-A1 | FLUORESCENT DYES, ENERGY TRANSFER COUPLES AND METHODS | MILLIPORE CORPORATION | 2006-11-16 | — | — | US | claimed |
| US-7091348-B2 | Fluorescent dyes, energy transfer couples and methods | GUAVA TECHNOLOGIES, INC. (US) | 2006-08-15 | — | — | US | claimed |
| EP-1539728-A2 | FLUORESCENT DYES, ENERGY TRANSFER COUPLES AND METHODS | Guava Technologies, Inc. (US) | 2005-06-15 | — | — | EP | claimed |
| US-20040073014-A1 | Fluorescent dyes, energy transfer couples and methods | EMD MILLIPORE CORPORATION | 2004-04-15 | — | — | US | claimed |
| WO-2004003510-A2 | FLUORESCENT DYES, ENERGY TRANSFER COUPLES AND METHODS | GUAVA TECHNOLOGIES, INC. (US) | 2004-01-08 | — | — | WO | claimed |
| EP-0386839-B1 | Tetrahydroquinoline derivatives useful for neurodegenerative disorders | MERCK SHARP & DOHME (GB) | 1997-01-15 | — | — | EP | claimed |
| US-11390604-B2 | Imidazole-pyrazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2022-07-19 | — | — | US | disclosed |
| EP-3934756-A1 | NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2022-01-12 | — | — | EP | disclosed |
| CN-113613722-A | Novel imidazole-pyrazole derivatives | 豪夫迈·罗氏有限公司 | 2021-11-05 | — | — | CN | disclosed |
| WO-2020182648-A1 | NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2020-09-17 | — | — | WO | disclosed |
| US-20200290998-A1 | NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2020-09-17 | — | — | US | disclosed |
| EP-2689031-B1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | ELITECHGROUP B V (NL) | 2016-10-19 | — | — | EP | disclosed |
| EP-2971086-A1 | FUNCTIONALIZED 3-ALKYNYL PYRAZOLOPYRIMIDINE ANALOGUES AS UNIVERSAL BASES AND METHODS OF USE | ELITechGroup B.V. (NL) | 2016-01-20 | — | — | EP | disclosed |
| US-20030224359-A1 | TMLEVELING METHODS | EPOCH BIOSCIENCES, INC. | 2003-12-04 | — | — | US | disclosed |
| EP-1261616-A2 | MODIFIED OLIGONUCLEOTIDES FOR MISMATCH DISCRIMINATION | Epoch Biosciences, Inc. (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001064958-A2 | MODIFIED OLIGONUCLEOTIDES FOR MISMATCH DISCRIMINATION | EPOCH BIOSCIENECS, INC. (US) | 2001-09-07 | — | — | WO | disclosed |
| EP-0386839-B1 | Tetrahydroquinoline derivatives useful for neurodegenerative disorders | MERCK SHARP & DOHME (GB) | 1997-01-15 | — | — | EP | disclosed |
| US-5472958-A | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function | ABBOTT LABORATORIES (US) | 1995-12-05 | — | — | US | disclosed |
| US-5231102-A | Tetrahydroquinoline derivatives useful for neurodegenerative disorders | MERCK SHARP & DOHME, LTD. (GB) | 1993-07-27 | — | — | US | disclosed |
| EP-0386839-A2 | Tetrahydroquinoline derivatives useful for neurodegenerative disorders | MERCK SHARP & DOHME LTD. (GB) | 1990-09-12 | — | — | EP | disclosed |